A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

July 31, 2005

Conditions

HypertensionInsulin ResistanceMetabolic Syndrome

Interventions

DRUG

Olmesartan medoxomil

DRUG

Losartan potassium

DRUG

Atenolol

Trial Locations (10)

Birmingham

San Diego

Miami

Indianapolis

Baltimore

Boston

Rochester

Philadelphia

Dallas

San Antonio